Zhongliu Fangzhi Yanjiu is a peer-reviewed chinese-language open-access journal published by Magazine House of Cancer Research on Prevention and Treatment in China, operating under an open-access model since 2008. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Zhongliu Fangzhi Yanjiu; refer to the journal's APC page for the current rate. Articles are released under the CC BY-NC license (see other journals using this license).
All submissions undergo plagiarism screening before peer review.
Keywords
surgery, chemotherapy, radiotherapy, epidemiology, immunotherapy
At a glance
ISSN
- 1000-8578
Frequently asked questions
Is Zhongliu Fangzhi Yanjiu peer-reviewed?
Yes — Zhongliu Fangzhi Yanjiu operates a Anonymous peer review review process.
Does Zhongliu Fangzhi Yanjiu charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate.
What subjects does Zhongliu Fangzhi Yanjiu publish?
Zhongliu Fangzhi Yanjiu publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Zhongliu Fangzhi Yanjiu accept?
Zhongliu Fangzhi Yanjiu accepts manuscripts in Chinese.
What is the ISSN of Zhongliu Fangzhi Yanjiu?
ISSN:
1000-8578 (print).How do I submit a manuscript to Zhongliu Fangzhi Yanjiu?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Zhongliu Fangzhi Yanjiu?
Average time from submission to publication is approximately 36 weeks.